RAPID MICRO BIOSYSTEMS INC-A (RPID) Fundamental Analysis & Valuation

NASDAQ:RPID • US75340L1044

Current stock price

2.38 USD
+0.19 (+8.68%)
Last:

This RPID fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. RPID Profitability Analysis

1.1 Basic Checks

  • RPID had negative earnings in the past year.
  • In the past year RPID has reported a negative cash flow from operations.
  • RPID had negative earnings in each of the past 5 years.
  • RPID had a negative operating cash flow in each of the past 5 years.
RPID Yearly Net Income VS EBIT VS OCF VS FCFRPID Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 -20M -40M -60M

1.2 Ratios

  • The Return On Assets of RPID (-62.95%) is worse than 87.50% of its industry peers.
  • The Return On Equity of RPID (-141.91%) is worse than 83.93% of its industry peers.
Industry RankSector Rank
ROA -62.95%
ROE -141.91%
ROIC N/A
ROA(3y)-49.1%
ROA(5y)-42.31%
ROE(3y)-82.87%
ROE(5y)-64.19%
ROIC(3y)N/A
ROIC(5y)N/A
RPID Yearly ROA, ROE, ROICRPID Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 0 1K 2K 3K

1.3 Margins

  • With a Gross Margin value of 3.12%, RPID is not doing good in the industry: 91.07% of the companies in the same industry are doing better.
  • The Profit Margin and Operating Margin are not available for RPID so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 3.12%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
RPID Yearly Profit, Operating, Gross MarginsRPID Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025 0 -100 -200 -300

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. RPID Health Analysis

2.1 Basic Checks

  • RPID does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for RPID has been increased compared to 1 year ago.
  • RPID has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, RPID has a worse debt to assets ratio.
RPID Yearly Shares OutstandingRPID Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M
RPID Yearly Total Debt VS Total AssetsRPID Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M

2.2 Solvency

  • Based on the Altman-Z score of -9.28, we must say that RPID is in the distress zone and has some risk of bankruptcy.
  • The Altman-Z score of RPID (-9.28) is worse than 91.07% of its industry peers.
  • A Debt/Equity ratio of 0.57 indicates that RPID is somewhat dependend on debt financing.
  • The Debt to Equity ratio of RPID (0.57) is worse than 62.50% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.57
Debt/FCF N/A
Altman-Z -9.28
ROIC/WACCN/A
WACC11.12%
RPID Yearly LT Debt VS Equity VS FCFRPID Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 0 50M -50M 100M 150M 200M

2.3 Liquidity

  • RPID has a Current Ratio of 3.31. This indicates that RPID is financially healthy and has no problem in meeting its short term obligations.
  • RPID has a better Current ratio (3.31) than 60.71% of its industry peers.
  • A Quick Ratio of 2.36 indicates that RPID has no problem at all paying its short term obligations.
  • The Quick ratio of RPID (2.36) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 3.31
Quick Ratio 2.36
RPID Yearly Current Assets VS Current LiabilitesRPID Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. RPID Growth Analysis

3.1 Past

  • The Earnings Per Share has been growing slightly by 0.93% over the past year.
  • RPID shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 19.74%.
  • RPID shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 15.87% yearly.
EPS 1Y (TTM)0.93%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-27.27%
Revenue 1Y (TTM)19.74%
Revenue growth 3Y25.16%
Revenue growth 5Y15.87%
Sales Q2Q%37.28%

3.2 Future

  • The Earnings Per Share is expected to grow by 11.13% on average over the next years. This is quite good.
  • RPID is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 22.46% yearly.
EPS Next Y11.98%
EPS Next 2Y10.23%
EPS Next 3Y13.11%
EPS Next 5Y11.13%
Revenue Next Year18.95%
Revenue Next 2Y18.69%
Revenue Next 3Y23.62%
Revenue Next 5Y22.46%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
RPID Yearly Revenue VS EstimatesRPID Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 20M 40M 60M 80M
RPID Yearly EPS VS EstimatesRPID Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 -0.5 -1 -1.5

More info and screens

Find the best growth stocksShow best growing peers

0

4. RPID Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for RPID. In the last year negative earnings were reported.
  • Also next year RPID is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
RPID Price Earnings VS Forward Price EarningsRPID Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
RPID Per share dataRPID EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 -1

4.3 Compensation for Growth

  • RPID's earnings are expected to grow with 13.11% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y10.23%
EPS Next 3Y13.11%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. RPID Dividend Analysis

5.1 Amount

  • RPID does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

RPID Fundamentals: All Metrics, Ratios and Statistics

RAPID MICRO BIOSYSTEMS INC-A

NASDAQ:RPID (4/22/2026, 4:30:02 PM)

2.38

+0.19 (+8.68%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)03-12
Earnings (Next)05-07
Inst Owners56.29%
Inst Owner Change0%
Ins Owners4.41%
Ins Owner Change9.44%
Market Cap108.93M
Revenue(TTM)33.59M
Net Income(TTM)-47.12M
Analysts84
Price Target8.16 (242.86%)
Short Float %1.04%
Short Ratio1.75
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-13.71%
Min EPS beat(2)-23.38%
Max EPS beat(2)-4.04%
EPS beat(4)1
Avg EPS beat(4)-6.58%
Min EPS beat(4)-23.38%
Max EPS beat(4)5.59%
EPS beat(8)3
Avg EPS beat(8)-3.45%
EPS beat(12)7
Avg EPS beat(12)0.83%
EPS beat(16)8
Avg EPS beat(16)0.25%
Revenue beat(2)0
Avg Revenue beat(2)-1.7%
Min Revenue beat(2)-2.55%
Max Revenue beat(2)-0.85%
Revenue beat(4)2
Avg Revenue beat(4)1.21%
Min Revenue beat(4)-2.55%
Max Revenue beat(4)7.03%
Revenue beat(8)6
Avg Revenue beat(8)3.77%
Revenue beat(12)10
Avg Revenue beat(12)6.44%
Revenue beat(16)11
Avg Revenue beat(16)3.28%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-5.72%
EPS NQ rev (3m)-17.46%
EPS NY rev (1m)-7.05%
EPS NY rev (3m)-7.68%
Revenue NQ rev (1m)-0.44%
Revenue NQ rev (3m)-14.61%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.63%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.24
P/FCF N/A
P/OCF N/A
P/B 3.28
P/tB 3.28
EV/EBITDA N/A
EPS(TTM)-1.07
EYN/A
EPS(NY)-0.94
Fwd EYN/A
FCF(TTM)-0.7
FCFYN/A
OCF(TTM)-0.68
OCFYN/A
SpS0.73
BVpS0.73
TBVpS0.73
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -62.95%
ROE -141.91%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 3.12%
FCFM N/A
ROA(3y)-49.1%
ROA(5y)-42.31%
ROE(3y)-82.87%
ROE(5y)-64.19%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.45
Health
Industry RankSector Rank
Debt/Equity 0.57
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 26.14%
Cap/Sales 2.53%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.31
Quick Ratio 2.36
Altman-Z -9.28
F-Score3
WACC11.12%
ROIC/WACCN/A
Cap/Depr(3y)42.05%
Cap/Depr(5y)114.79%
Cap/Sales(3y)5.2%
Cap/Sales(5y)13.76%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)0.93%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-27.27%
EPS Next Y11.98%
EPS Next 2Y10.23%
EPS Next 3Y13.11%
EPS Next 5Y11.13%
Revenue 1Y (TTM)19.74%
Revenue growth 3Y25.16%
Revenue growth 5Y15.87%
Sales Q2Q%37.28%
Revenue Next Year18.95%
Revenue Next 2Y18.69%
Revenue Next 3Y23.62%
Revenue Next 5Y22.46%
EBIT growth 1Y5.06%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year17.73%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y29.89%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y29.65%
OCF growth 3YN/A
OCF growth 5YN/A

RAPID MICRO BIOSYSTEMS INC-A / RPID Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for RAPID MICRO BIOSYSTEMS INC-A?

ChartMill assigns a fundamental rating of 2 / 10 to RPID.


Can you provide the valuation status for RAPID MICRO BIOSYSTEMS INC-A?

ChartMill assigns a valuation rating of 0 / 10 to RAPID MICRO BIOSYSTEMS INC-A (RPID). This can be considered as Overvalued.


What is the profitability of RPID stock?

RAPID MICRO BIOSYSTEMS INC-A (RPID) has a profitability rating of 0 / 10.


Can you provide the financial health for RPID stock?

The financial health rating of RAPID MICRO BIOSYSTEMS INC-A (RPID) is 3 / 10.